Open

Coming up

Don't miss

Replay


LATEST SHOWS

WEB NEWS

Online scammers exploit MH17 crash

Read more

MEDIAWATCH

Too many graphic images from Gaza ?

Read more

MEDIAWATCH

Gaza: online reactions

Read more

BUSINESS DAILY

Rise of the Robots

Read more

FOCUS

Overfishing and the global appetite for bluefin tuna: can Tokyo turn the tide?

Read more

DEBATE

Israel-Gaza, From Bad to Worse? With no Ceasefire in Sight, Conflict Spillover Felt Elsewhere (part 2)

Read more

DEBATE

Israel-Gaza, From Bad to Worse? With no Ceasefire in Sight, Conflict Spillover Felt Elsewhere

Read more

EUROPE NOW

Best of Europe Now (Part 1)

Read more

ENCORE!

Clapton pays hommage to 'Cocaine' songwriter J.J. Cale

Read more

  • Hollande says French warship delivery will ‘depend on Russia’s attitude’

    Read more

  • Israeli soldier missing in Gaza, says media reports

    Read more

  • Ukraine rebels release bodies, black boxes from flight MH17

    Read more

  • A call for harmony in riot-hit ‘Little Jerusalem’ suburb of Paris

    Read more

  • An ‘explosion of violence’: French press reacts to Gaza protests

    Read more

  • Notorious ‘VIP’ prison in Paris closed for renovations

    Read more

  • Christians in Iraq's Mosul face execution or exodus

    Read more

  • Scores killed as Libyan militias fight over airport

    Read more

  • Ukraine football players refuse to return home after friendly in France

    Read more

  • China steps up communist education to guard against ‘moral decline’

    Read more

  • France slams ‘anti-Semitic’ violence at pro-Palestinian rally

    Read more

  • French rugby stars attacked with machetes and swords

    Read more

  • Hollande announces new military operation in West Africa

    Read more

  • Kristoff wins Tour’s flat Stage 15

    Read more

Sanofi-Aventis withdraws anti-obesity drug from European shelves

Text by AFP

Latest update : 2008-10-24

EU authorities have suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent, due to an abnormal risk of psychiatric problems.

EU authorities suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent Thursday, the firm announced, adding that it had not ruled out a worldwide halt.

"Sales have been halted in all the pharmacies in the 18 countries of the European Union where it is distributed," a company spokesman told AFP.

Sanofi-Aventis said the European Medicines Agency (EMEA) had warned that patients taking the drug ran almost double the normal risk of psychiatric problems.

"The risks of taking Acomplia are now greater than the benefits that the drug can bring the patient according to its current guidelines," the company said, citing the EMEA.

Europe has allowed sales of Acomplia since 2006, but it has not been authorised in the United States where authorities believe it encourages suicidal thoughts, even in patients with no history of depression.

The company said it had not ruled out withdrawing the drug in the 14 non-EU countries where it is sold. It said users of the drug should consult a doctor or pharmacist.
 

Date created : 2008-10-24

COMMENT(S)